Opaleye, L.P. 4
4 · ArTara Therapeutics, Inc. · Filed Jan 13, 2020
Insider Transaction Report
Form 4
Opaleye, L.P.
10% Owner
Transactions
- Award
Common Stock
2020-01-09+777,635→ 782,238 total - Award
Common Stock
2020-01-09$7.01/sh+1,426,234$9,997,900→ 2,208,472 total
Footnotes (2)
- [F1]On September 23, 2019, the Issuer entered into an Agreement and Plan of Merger and Reorganization (the "Merger Agreement") as amended on November 19, 2019, with the Issuer, REM 1 Acquisition, Inc. ("Merger Sub") and ArTara Subsidiary, Inc. ("ArTara Sub"). On January 9, 2020 (the "Effective Time"), Merger Sub was merged with and into ArTara Sub, with ArTara Sub surviving as a wholly-owned subsidiary of the Issuer.
- [F2]These shares were received in exchange for: i) 571,428 shares of ArTara Sub common stock; and ii) 3,505,174 shares of ArTara Sub exchangeable common stock, in connection with the merger.